Answers are grounded in this paper and cite their sources.
We discuss how corruption affects access to antiretroviral therapies (ARVs) globally. Recent cases of theft of ARVs, collusion, and manipulation in procurement found in countries such as Central African Republic, Bangladesh, Malawi, and Guinea, show there is still much work to be done to reduce the risk of corruption. This includes addressing the structural weaknesses in procurement mechanisms and supply chain management systems of health commodities and medicines.
No takes yet. Share an insight, caveat, or question.
Köhler et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: